RVTY:NYSE
Revvity Inc
US$86.77
arrow_downward
-0.44%(-0.38) 1D
US$86.77
0.00% (0.00)
bedtime시간 외 거래
휴장: 4월 24일, 오후 4시 0분 5초 GMT-4 · USD
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoRVTY의 주요 통계 생성 중...
시가
US$87.27
고가
US$88.12
저가
US$85.58
시가총액
97.01억
평균 거래량
96.28만
거래량
124.81만
52주 최고가
US$118.30
52주 최저가
US$81.36
베타
1.13
유통 주식수
1.12억
직원 수
1만
뉴스 기사
웹 소스 기반
프로필
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.
In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY. Wikipedia
Revvity Inc에 관한 정보